Lucid Diagnostics, Inc. (LUCD)
0.4077
+0.01
(+2.18%)
USD |
NASDAQ |
Nov 18, 16:00
0.399
-0.01
(-2.13%)
After-Hours: 20:00
Lucid Diagnostics Max Drawdown (5Y) : 96.99% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 96.99% |
| September 30, 2026 | 94.30% |
| August 31, 2026 | 94.30% |
| July 31, 2026 | 94.30% |
| June 30, 2026 | 94.30% |
| May 31, 2026 | 94.30% |
| Date | Value |
|---|---|
| April 30, 2026 | 94.30% |
| March 31, 2026 | 94.30% |
| February 28, 2026 | 94.30% |
| January 31, 2026 | 94.30% |
| December 31, 2025 | 94.30% |
| November 30, 2025 | 94.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| PAVmed, Inc. | 99.92% |
| Stereotaxis, Inc. | 87.39% |
| Glaukos Corp. | 64.32% |
| CVRx, Inc. | 96.06% |
| Hyperfine, Inc. | 95.01% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -60.94 |
| Beta (5Y) | 1.191 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 66.06% |
| Historical Sharpe Ratio (5Y) | -0.7745 |
| Historical Sortino (5Y) | -1.272 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.99% |